Dynavax Technologies 8-K Filing: Key Corporate Update on January 13, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: Dynavax Technologies Corporation
- CIK Number: 0001029142
- SEC Central Index Key (CIK): This number is unique and helps identify the company in SEC filings.
- Filing Details:
- Form Type: 8-K (a report of unscheduled material events or corporate changes that are of importance to shareholders)
- Filing Date: January 13, 2025
- Business Location:
- Address: 2100 Powell Street, Suite 720, Emeryville, CA 94608
- Phone Number: 510-848-5100
- Stock Information:
- Common Stock Par Value: $0.001
- Ticker Symbol: DVAX
- Exchange: NASDAQ
- Period of Reporting:
- Start Date: January 13, 2025
- End Date: January 13, 2025
Insights:
- The filing indicates a specific event or change that Dynavax Technologies Corporation deemed significant enough to report to the SEC. As an 8-K filing, it typically covers material events that could affect the company's financial position or operations.
- The document is structured in XBRL format, which is used for electronic submissions to the SEC, indicating adherence to standardized reporting practices.
- The company is identified with a clear unique identifier (CIK), which is essential for tracking its filings and financial health over time.
Overall, this entry suggests that investors should review the associated 8-K filing for potential impacts on the company's stock performance or operational changes.